Logo image of SE

SEA LTD-ADR (SE) Stock Fundamental Analysis

USA - NYSE:SE - US81141R1005 - ADR

149.94 USD
-3.62 (-2.36%)
Last: 11/7/2025, 8:16:59 PM
151 USD
+1.06 (+0.71%)
After Hours: 11/7/2025, 8:16:59 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SE. SE was compared to 30 industry peers in the Broadline Retail industry. SE has only an average score on both its financial health and profitability. SE is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SE had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: SE reported negative net income in multiple years.
Of the past 5 years SE 4 years had a positive operating cash flow.
SE Yearly Net Income VS EBIT VS OCF VS FCFSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

1.2 Ratios

The Return On Assets of SE (4.70%) is comparable to the rest of the industry.
With a decent Return On Equity value of 12.35%, SE is doing good in the industry, outperforming 70.00% of the companies in the same industry.
SE has a Return On Invested Capital (6.56%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.7%
ROE 12.35%
ROIC 6.56%
ROA(3y)-2.32%
ROA(5y)-6.67%
ROE(3y)-7.1%
ROE(5y)-19.36%
ROIC(3y)N/A
ROIC(5y)N/A
SE Yearly ROA, ROE, ROICSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

With a decent Profit Margin value of 6.17%, SE is doing good in the industry, outperforming 70.00% of the companies in the same industry.
The Operating Margin of SE (7.49%) is better than 63.33% of its industry peers.
SE's Gross Margin of 44.96% is in line compared to the rest of the industry. SE outperforms 56.67% of its industry peers.
SE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.49%
PM (TTM) 6.17%
GM 44.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.06%
GM growth 5Y9.02%
SE Yearly Profit, Operating, Gross MarginsSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SE is destroying value.
SE has less shares outstanding than it did 1 year ago.
SE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SE has an improved debt to assets ratio.
SE Yearly Shares OutstandingSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SE Yearly Total Debt VS Total AssetsSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

SE has an Altman-Z score of 4.34. This indicates that SE is financially healthy and has little risk of bankruptcy at the moment.
SE has a Altman-Z score of 4.34. This is in the better half of the industry: SE outperforms 76.67% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that SE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, SE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.34
ROIC/WACC0.78
WACC8.46%
SE Yearly LT Debt VS Equity VS FCFSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

2.3 Liquidity

SE has a Current Ratio of 1.55. This is a normal value and indicates that SE is financially healthy and should not expect problems in meeting its short term obligations.
SE has a Current ratio of 1.55. This is comparable to the rest of the industry: SE outperforms 53.33% of its industry peers.
SE has a Quick Ratio of 1.54. This is a normal value and indicates that SE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.54, SE is doing good in the industry, outperforming 76.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
SE Yearly Current Assets VS Current LiabilitesSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 651.43% over the past year.
The Revenue has grown by 33.95% in the past year. This is a very strong growth!
SE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.55% yearly.
EPS 1Y (TTM)651.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%364.29%
Revenue 1Y (TTM)33.95%
Revenue growth 3Y19.1%
Revenue growth 5Y50.55%
Sales Q2Q%38.16%

3.2 Future

The Earnings Per Share is expected to grow by 106.94% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.50% on average over the next years. This is quite good.
EPS Next Y336.41%
EPS Next 2Y160.51%
EPS Next 3Y106.94%
EPS Next 5YN/A
Revenue Next Year32.26%
Revenue Next 2Y27.24%
Revenue Next 3Y23.39%
Revenue Next 5Y19.5%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SE Yearly Revenue VS EstimatesSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SE Yearly EPS VS EstimatesSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 77.69, the valuation of SE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SE is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 25.83. SE is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 30.26, the valuation of SE can be described as expensive.
SE's Price/Forward Earnings ratio is in line with the industry average.
SE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 32.68.
Industry RankSector Rank
PE 77.69
Fwd PE 30.26
SE Price Earnings VS Forward Price EarningsSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

SE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SE is more expensive than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.15
SE Per share dataSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SE's earnings are expected to grow with 106.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y160.51%
EPS Next 3Y106.94%

0

5. Dividend

5.1 Amount

SE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SEA LTD-ADR

NYSE:SE (11/7/2025, 8:16:59 PM)

After market: 151 +1.06 (+0.71%)

149.94

-3.62 (-2.36%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners69.03%
Inst Owner Change-1.73%
Ins Owners7.52%
Ins Owner Change0%
Market Cap88.77B
Revenue(TTM)19.38B
Net Income(TTM)1.20B
Analysts81.5
Price Target202.71 (35.19%)
Short Float %5.34%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.71%
Min EPS beat(2)-9.85%
Max EPS beat(2)0.44%
EPS beat(4)1
Avg EPS beat(4)-7.94%
Min EPS beat(4)-12.96%
Max EPS beat(4)0.44%
EPS beat(8)2
Avg EPS beat(8)-123.81%
EPS beat(12)5
Avg EPS beat(12)-73.91%
EPS beat(16)6
Avg EPS beat(16)-61.5%
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)2.6%
Revenue beat(4)3
Avg Revenue beat(4)1.44%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)3.98%
Revenue beat(8)5
Avg Revenue beat(8)1.18%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)10
Avg Revenue beat(16)1.48%
PT rev (1m)1.37%
PT rev (3m)12.09%
EPS NQ rev (1m)-5.97%
EPS NQ rev (3m)-3.12%
EPS NY rev (1m)0.19%
EPS NY rev (3m)4.93%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)5.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.3%
Valuation
Industry RankSector Rank
PE 77.69
Fwd PE 30.26
P/S 4.58
P/FCF N/A
P/OCF N/A
P/B 9.17
P/tB 9.29
EV/EBITDA 41.15
EPS(TTM)1.93
EY1.29%
EPS(NY)4.95
Fwd EY3.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.73
BVpS16.35
TBVpS16.14
PEG (NY)0.23
PEG (5Y)N/A
Graham Number26.64
Profitability
Industry RankSector Rank
ROA 4.7%
ROE 12.35%
ROCE 11.43%
ROIC 6.56%
ROICexc 14.21%
ROICexgc 14.43%
OM 7.49%
PM (TTM) 6.17%
GM 44.96%
FCFM N/A
ROA(3y)-2.32%
ROA(5y)-6.67%
ROE(3y)-7.1%
ROE(5y)-19.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.06%
GM growth 5Y9.02%
F-ScoreN/A
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 3.43
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 4.34
F-ScoreN/A
WACC8.46%
ROIC/WACC0.78
Cap/Depr(3y)123.02%
Cap/Depr(5y)171.16%
Cap/Sales(3y)3.91%
Cap/Sales(5y)5.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)651.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%364.29%
EPS Next Y336.41%
EPS Next 2Y160.51%
EPS Next 3Y106.94%
EPS Next 5YN/A
Revenue 1Y (TTM)33.95%
Revenue growth 3Y19.1%
Revenue growth 5Y50.55%
Sales Q2Q%38.16%
Revenue Next Year32.26%
Revenue Next 2Y27.24%
Revenue Next 3Y23.39%
Revenue Next 5Y19.5%
EBIT growth 1Y4903.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year454.65%
EBIT Next 3Y114.56%
EBIT Next 5Y69.97%
FCF growth 1Y62.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.59%
OCF growth 3Y150.46%
OCF growth 5Y115.88%

SEA LTD-ADR / SE FAQ

Can you provide the ChartMill fundamental rating for SEA LTD-ADR?

ChartMill assigns a fundamental rating of 4 / 10 to SE.


Can you provide the valuation status for SEA LTD-ADR?

ChartMill assigns a valuation rating of 3 / 10 to SEA LTD-ADR (SE). This can be considered as Overvalued.


How profitable is SEA LTD-ADR (SE) stock?

SEA LTD-ADR (SE) has a profitability rating of 4 / 10.


How financially healthy is SEA LTD-ADR?

The financial health rating of SEA LTD-ADR (SE) is 4 / 10.


What is the expected EPS growth for SEA LTD-ADR (SE) stock?

The Earnings per Share (EPS) of SEA LTD-ADR (SE) is expected to grow by 336.41% in the next year.